MicroPort Orthopedics and Pixee Medical Commercialize Surgical Solution in the U.S.

MicroPort Orthopedics, a leader in orthopedic devices and technologies, has expanded its partnership with Pixee Medical through the commercialization of its combined surgical solution in the United States.
 
Utilizing Pixee Medical’s FDA-cleared augmented reality surgical application for assistance in total knee arthroplasty, the surgeon can achieve precision and control when implanting MicroPort Evolution Medial-Pivot Knee Implant. This solution is currently being used in thousands of successful cases around the world including in Australia, Europe, and Asia.
 
The MicroPort Orthopedics Evolution Medial-Pivot Knee Implant delivers a high degree of stability and motion, leading to increased patient satisfaction and survivorship¹. The Pixee Medical Knee+ is a patented platform designed to assist orthopedic surgeons to perform surgeries better and faster by providing real-time positioning of instruments, right in their field of view via smart glasses. Combining MicroPort’s innovative devices with Pixee Medical’s platform is allowing patients, worldwide, access to surgery solutions integrating top of the class technologies.
 
“After much success around the world, we are excited to bring Pixee’s transformative technology to the United States for continued efficiency and precision of our device systems,” said Rob Cripe, chief commercial officer at MicroPort Orthopedics. “Our mission at MicroPort is to help the patient achieve Full Function, Faster – and the enhanced precision and efficiency this technology provides will help ensure this happens.”
 
“Combining MicroPort’s innovative devices and our platform is allowing patients, worldwide, access to surgery solutions that provide them with a faster recovery,” said Sébastien Henry, CEO at Pixee Medical. “Companies partnering in this orthopedic ecosystem are providing options to patients that weren’t available before now to improve their recovery and overall quality of life.”
 
This technology will be presented for the first time to U.S. surgeons at the Annual 2022 AAHKS meeting from November 3-6.
 
Reference:
¹ Based on a retrospective study of Advance Medial-Pivot. Macheras GA et al A long term clinical outcome of the Medial Pivot Knee Arthroplasty System. Knee. 2017 Mar.; 24(2):447-453